Amundi Index Solutions - Amundi Index MSCI Emerging Markets SRI PAB UCITS ETF DR C | MSRURegistrer dig for at låse op for ratings |
Fondens performance | 30-04-2024 |
Vækst af 1.000 (DKK) | Avanceret graf |
Fond | 7,4 | 5,5 | -12,7 | -2,4 | 1,3 | |
+/-Kat | -0,2 | 0,6 | 4,1 | -9,2 | -4,8 | |
+/-Indeks | 0,0 | -0,1 | 0,1 | -9,1 | -5,0 | |
Kategori: Aktier - Globale Nye Markeder | ||||||
Kategoribenchmark: Morningstar EM TME NR USD |
Oversigt | ||
Closing Price 17-05-2024 | USD 54,72 | |
Kursændring 1 dag | 0,27% | |
Morningstar Kategori™ | Aktier - Globale Nye Markeder | |
Omsætning | 0 | |
Børs | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1861138961 | |
Markedsværdi i alt (mio.) 16-05-2024 | USD 2140,82 | |
Seneste TNA(mio.) 16-05-2024 | USD 1345,63 | |
Løbende omkostning 10-11-2023 | 0,25% | |
Investeringsstrategi | Passiv |
Investeringsmålsætning: Amundi Index Solutions - Amundi Index MSCI Emerging Markets SRI PAB UCITS ETF DR C | MSRU |
To track the performance of MSCI EM (Emerging Markets) SRI Filtered PAB Index ("the Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager navn Startdato | ||
David Heard 31-01-2022 | ||
Zhicong Mou 07-01-2021 | ||
Klik her for at se flere | ||
Startdato 16-01-2019 |
Annonce |
Kategoribenchmark | |
Fondens indeks | Morningstar indeks |
MSCI EM SRI Filterd PAB NR USD | Morningstar EM TME NR USD |
Target Market | ||||||||||||||||||||
|
Formuefordeling Amundi Index Solutions - Amundi Index MSCI Emerging Markets SRI PAB UCITS ETF DR C | MSRU | 15-05-2024 |
|
|
Top 5 placeringer | Sektor | % |
Taiwan Semiconductor Manufacturi... | Teknologi | 5,71 |
Meituan Class B | Cyklisk forbrug | 5,12 |
Naspers Ltd Class N | Kommunikationsservice | 2,98 |
NetEase Inc Ordinary Shares | Kommunikationsservice | 2,51 |
BYD Co Ltd Class H | Cyklisk forbrug | 2,17 |
Øget Mindsket Ny siden sidste portefølje | ||
Amundi Index Solutions - Amundi Index MSCI Emerging Markets SRI PAB UCITS ETF DR C | MSRU |